Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 405

1.

Use of MIRUS™ for MAC-driven application of isoflurane, sevoflurane, and desflurane in postoperative ICU patients: a randomized controlled trial.

Bellgardt M, Georgevici AI, Klutzny M, Drees D, Meiser A, Gude P, Vogelsang H, Weber TP, Herzog-Niescery J.

Ann Intensive Care. 2019 Oct 16;9(1):118. doi: 10.1186/s13613-019-0594-8.

PMID:
31620921
2.

Prophylactic Surgery and Extended Oncologic Radicality in Gastric and Colorectal Hereditary Cancer Syndromes.

Vogelsang HE.

Visc Med. 2019 Aug;35(4):231-239. doi: 10.1159/000501919. Epub 2019 Jul 16. Review.

PMID:
31602384
3.

Advancing Screening and Prevention to the Next Level!

Allescher HD, Vogelsang HE.

Visc Med. 2019 Aug;35(4):203. doi: 10.1159/000501942. Epub 2019 Jul 26. No abstract available.

PMID:
31602379
4.

Prevalence and indicators of use of complementary and alternative medicine in Austrian patients with inflammatory bowel disease.

Gröchenig HP, Waldhör T, Haas T, Wenzl H, Steiner P, Koch R, Feichtenschlager T, Eckhardt G, Mayer A, Kirchgatterer A, Ludwiczek O, Platzer R, Papay P, Gartner J, Fuchssteiner H, Miehsler W, Peters PG, Reicht G, Kutschera M, Dejaco C, Vogelsang H, Novacek G; Austrian IBD Study Group (ATISG).

Eur J Gastroenterol Hepatol. 2019 Oct;31(10):1211-1219. doi: 10.1097/MEG.0000000000001533.

PMID:
31498280
5.

Photoacoustic gas monitoring for anesthetic gas pollution measurements and its cross-sensitivity to alcoholic disinfectants.

Herzog-Niescery J, Steffens T, Bellgardt M, Breuer-Kaiser A, Gude P, Vogelsang H, Weber TP, Seipp HM.

BMC Anesthesiol. 2019 Aug 9;19(1):148. doi: 10.1186/s12871-019-0822-7.

6.

Comparison of 3 Methods to Assess Occupational Sevoflurane Exposure in Abdominal Surgeons: A Single-Center Observational Pilot Study.

Herzog-Niescery J, Seipp HM, Bellgardt M, Herzog T, Belyaev O, Uhl W, Gude P, Weber TP, Vogelsang H.

Anesth Analg. 2019 Jul 5. doi: 10.1213/ANE.0000000000004301. [Epub ahead of print]

PMID:
31295179
7.

Kinetics of isoflurane and sevoflurane in a unidirectional displacement flow and the relevance to anesthetic gas exposure by operating room personnel.

Herzog-Niescery J, Bartz H, Vogelsang H, Bunse J, Maier-Hasselmann A, Bellgardt M, Gude P, Weber TP, Seipp HM.

J Occup Environ Hyg. 2019 Apr;16(4):294-301. doi: 10.1080/15459624.2019.1577965. Epub 2019 Mar 9.

PMID:
30852983
8.

Diagnostic delay in patients with inflammatory bowel disease in Austria.

Novacek G, Gröchenig HP, Haas T, Wenzl H, Steiner P, Koch R, Feichtenschlager T, Eckhardt G, Mayer A, Kirchgatterer A, Ludwiczek O, Platzer R, Papay P, Gartner J, Fuchssteiner H, Miehsler W, Peters PG, Reicht G, Vogelsang H, Dejaco C, Waldhör T; Austrian IBD Study Group (ATISG).

Wien Klin Wochenschr. 2019 Mar;131(5-6):104-112. doi: 10.1007/s00508-019-1451-3. Epub 2019 Feb 4.

PMID:
30715607
9.

The Personnel's Sevoflurane Exposure in the Postanesthesia Care Unit Measured by Photoacoustic Gas Monitoring and Hexafluoroisopropanol Biomonitoring.

Herzog-Niescery J, Vogelsang H, Bellgardt M, Seipp HM, Weber TP, Gude P.

J Perianesth Nurs. 2019 Jun;34(3):606-613. doi: 10.1016/j.jopan.2018.10.005. Epub 2019 Jan 18.

PMID:
30665744
10.

[Transfer of a cockpit strategy to anesthesiology : Clinical example: introduction of canned decisions to solve cannot intubate cannot oxygenate situations].

Vogelsang H, Botteck NM, Herzog-Niescery J, Kirov J, Litschko D, Weber TP, Gude P.

Anaesthesist. 2019 Jan;68(1):30-38. doi: 10.1007/s00101-018-0511-9. Epub 2018 Nov 16. German.

PMID:
30446807
11.

Comparison of perioperative strategies in ICD patients: The perioperative ICD management study (PIM study).

Neubauer H, Wellmann M, Herzog-Niescery J, Wutzler A, Weber TP, Mügge A, Vogelsang H.

Pacing Clin Electrophysiol. 2018 Nov;41(11):1536-1542. doi: 10.1111/pace.13514. Epub 2018 Oct 11.

PMID:
30264871
12.

Environmental safety: Air pollution while using MIRUS™ for short-term sedation in the ICU.

Herzog-Niescery J, Vogelsang H, Gude P, Seipp HM, Uhl W, Weber TP, Bellgardt M.

Acta Anaesthesiol Scand. 2019 Jan;63(1):86-92. doi: 10.1111/aas.13222. Epub 2018 Aug 7.

PMID:
30088264
13.

[Need of analgetics in children aged 2-12 years after tonsil surgery].

Gude P, Rieckert C, Bissantz N, Weber TP, Vogelsang H, Dazert S, Thomas JP.

Laryngorhinootologie. 2018 Jul;97(7):465-473. doi: 10.1055/a-0596-7675. Epub 2018 Apr 16. German.

PMID:
29660744
14.

Use of the MIRUS™ system for general anaesthesia during surgery: a comparison of isoflurane, sevoflurane and desflurane.

Bellgardt M, Drees D, Vinnikov V, Procopiuc L, Meiser A, Bomberg H, Gude P, Vogelsang H, Weber TP, Herzog-Niescery J.

J Clin Monit Comput. 2018 Aug;32(4):623-627. doi: 10.1007/s10877-018-0138-z. Epub 2018 Apr 9.

PMID:
29633099
15.

[Second Austrian consensus on the safe use of anti-TNFα-antibodies in patients with inflammatory bowel diseases].

Miehsler W, Dejaco C, Gröchenig HP, Fuchssteiner H, Högenauer C, Kazemi-Shirazi L, Maier H, Mayer A, Moschen A, Reinisch W, Petritsch W, Platzer R, Steiner P, Tilg H, Vogelsang H, Wenzl H, Novacek G.

Z Gastroenterol. 2018 Mar;56(3):275-302. doi: 10.1055/s-0044-100044. Epub 2018 Mar 12. German.

PMID:
29529682
16.

[Inflammatory bowel disease : What does the clinician want to know from the radiologist?]

Primas C, Vogelsang H, Bergmann M.

Radiologe. 2018 Apr;58(4):320-325. doi: 10.1007/s00117-018-0375-7. Review. German.

PMID:
29511770
17.

Prediction of Individual Serum Infliximab Concentrations in Inflammatory Bowel Disease by a Bayesian Dashboard System.

Eser A, Primas C, Reinisch S, Vogelsang H, Novacek G, Mould DR, Reinisch W.

J Clin Pharmacol. 2018 Jun;58(6):790-802. doi: 10.1002/jcph.1069. Epub 2018 Jan 30.

PMID:
29381220
18.

The child's behavior during inhalational induction and its impact on the anesthesiologist's sevoflurane exposure.

Herzog-Niescery J, Vogelsang H, Bellgardt M, Botteck NM, Seipp HM, Bartz H, Weber TP, Gude P.

Paediatr Anaesth. 2017 Dec;27(12):1247-1252. doi: 10.1111/pan.13269. Epub 2017 Oct 25.

PMID:
29071770
19.

ROC-king onwards: intraepithelial lymphocyte counts, distribution and role in coeliac disease mucosal interpretation.

Oberhuber G, Moschen A, Entenmann A, Vogelsang H.

Gut. 2018 Nov;67(11):2069. doi: 10.1136/gutjnl-2017-315403. Epub 2017 Oct 21. No abstract available.

PMID:
29055910
20.

Effect of PF-00547659 on Central Nervous System Immune Surveillance and Circulating β7+ T Cells in Crohn's Disease: Report of the TOSCA Study.

D'Haens G, Vermeire S, Vogelsang H, Allez M, Desreumaux P, Van Gossum A, Sandborn WJ, Baumgart DC, Ransohoff RM, Comer GM, Ahmad A, Cataldi F, Cheng J, Clare R, Gorelick KJ, Kaminski A, Pradhan V, Rivers S, Sikpi MO, Zhang Y, Hassan-Zahraee M, Reinisch W, Stuve O.

J Crohns Colitis. 2018 Jan 24;12(2):188-196. doi: 10.1093/ecco-jcc/jjx128.

21.

The impact of the anesthetic conserving device on occupational exposure to isoflurane among intensive care healthcare professionals.

Herzog-Niescery J, Vogelsang H, Gude P, Seipp HM, Bartz H, Uhl W, Weber TP, Bellgardt M.

Minerva Anestesiol. 2018 Jan;84(1):25-32. doi: 10.23736/S0375-9393.17.11770-0. Epub 2017 Jun 14.

22.

Letter: refractory coeliac disease and coeliac-specific serology status - authors' reply.

Eigner W, Vogelsang H.

Aliment Pharmacol Ther. 2017 Mar;45(6):862-863. doi: 10.1111/apt.13966. No abstract available.

23.

Dynamics of occurrence of refractory coeliac disease and associated complications over 25 years.

Eigner W, Bashir K, Primas C, Kazemi-Shirazi L, Wrba F, Trauner M, Vogelsang H.

Aliment Pharmacol Ther. 2017 Jan;45(2):364-372. doi: 10.1111/apt.13867. Epub 2016 Nov 25.

24.

Platelets Toll-like receptor-4 in Crohns disease.

Schmid W, Novacek G, Vogelsang H, Papay P, Primas C, Eser A, Panzer S.

Eur J Clin Invest. 2017 Feb;47(2):109-116. doi: 10.1111/eci.12686. Epub 2016 Dec 29.

PMID:
27714784
25.

Clinical and Immunologic Features of Ultra-Short Celiac Disease.

Oberhuber G, Vogelsang H.

Gastroenterology. 2016 Oct;151(4):773. doi: 10.1053/j.gastro.2016.06.053. Epub 2016 Aug 30. No abstract available.

PMID:
27590688
26.

[Epidemiological study on place of death for cancer patients Autoren].

Dasch B, Blum K, Vogelsang H, Bausewein C.

Dtsch Med Wochenschr. 2016 Aug;141(17):e158-65. doi: 10.1055/s-0042-111296. Epub 2016 Aug 24. German.

PMID:
27557075
27.

Surgeons' exposure to sevoflurane during paediatric adenoidectomy: a comparison of three airway devices.

Herzog-Niescery J, Gude P, Gahlen F, Seipp HM, Bartz H, Botteck NM, Bellgardt M, Dazert S, Weber TP, Vogelsang H.

Anaesthesia. 2016 Aug;71(8):915-20. doi: 10.1111/anae.13515. Epub 2016 Jun 9.

28.

The efficacy and safety of either infliximab or adalimumab in 362 patients with anti-TNF-α naïve Crohn's disease.

Narula N, Kainz S, Petritsch W, Haas T, Feichtenschlager T, Novacek G, Eser A, Vogelsang H, Reinisch W, Papay P.

Aliment Pharmacol Ther. 2016 Jul;44(2):170-80. doi: 10.1111/apt.13671. Epub 2016 May 26.

29.

Vedolizumab in der Behandlung der Colitis ulcerosa und des Morbus Crohn - ein Konsensus der Arbeitsgruppe "Chronisch Entzündliche Darmerkrankungen" der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie.

Novacek G, Dejaco C, Gröchenig HP, Högenauer C, Knoflach P, Miehsler W, Moschen A, Petritsch W, Vogelsang H, Tilg H.

Z Gastroenterol. 2016 May;54(5):456-67. doi: 10.1055/s-0042-103694. Epub 2016 Mar 16. German. No abstract available.

PMID:
26982099
30.

Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults.

Leitner GC, Vogelsang H.

World J Gastrointest Pharmacol Ther. 2016 Feb 6;7(1):5-20. doi: 10.4292/wjgpt.v7.i1.5. Review.

31.

Prime and boost aerosol exposure via fog machine or shisha smoke followed by cinnamon hypersensitivity and anaphylaxis to spiced food.

Jensen-Jarolim E, Roth-Walter F, Leitner E, Buchleitner S, Vogelsang H, Kinaciyan T.

World Allergy Organ J. 2016 Jan 27;9:4. doi: 10.1186/s40413-016-0091-6. eCollection 2016.

32.

Anogenital Human Papillomavirus Prevalence is Unaffected by Therapeutic Tumour Necrosis Factor-alpha Inhibition.

Handisurya A, Lázár S, Papay P, Primas C, Haitel A, Horvat R, Tanew A, Vogelsang H, Kirnbauer R.

Acta Derm Venereol. 2016 May;96(4):494-8. doi: 10.2340/00015555-2298.

33.

Occupational Chronic Sevoflurane Exposure in the Everyday Reality of the Anesthesia Workplace.

Herzog-Niescery J, Botteck NM, Vogelsang H, Gude P, Bartz H, Weber TP, Seipp HM.

Anesth Analg. 2015 Dec;121(6):1519-28. doi: 10.1213/ANE.0000000000001015.

PMID:
26579657
34.

Reply to: Mucosal histopathology in celiac disease: a rebuttal of Oberhuber´s subdivision of Marsh III.

Oberhuber G, Vogelsang H.

Gastroenterol Hepatol Bed Bench. 2015 Fall;8(4):302. No abstract available.

35.

Safety and Efficacy of an Oral Inhibitor of the Purinergic Receptor P2X7 in Adult Patients with Moderately to Severely Active Crohn's Disease: A Randomized Placebo-controlled, Double-blind, Phase IIa Study.

Eser A, Colombel JF, Rutgeerts P, Vermeire S, Vogelsang H, Braddock M, Persson T, Reinisch W.

Inflamm Bowel Dis. 2015 Oct;21(10):2247-53. doi: 10.1097/MIB.0000000000000514.

PMID:
26197451
36.

Usefulness of recombinant γ-gliadin 1 for identifying patients with celiac disease and monitoring adherence to a gluten-free diet.

Srinivasan B, Focke-Tejkl M, Weber M, Pahr S, Baar A, Atreya R, Neurath MF, Vogelsang H, Huber WD, Valenta R.

J Allergy Clin Immunol. 2015 Dec;136(6):1607-1618.e3. doi: 10.1016/j.jaci.2015.04.040. Epub 2015 Jun 13.

37.

A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease.

Reinisch W, Altorjay I, Zsigmond F, Primas C, Vogelsang H, Novacek G, Reinisch S, Thomsen LL.

Scand J Gastroenterol. 2015;50(10):1226-33. doi: 10.3109/00365521.2015.1031168. Epub 2015 Apr 21.

38.

Survival after long-term isoflurane sedation as opposed to intravenous sedation in critically ill surgical patients: Retrospective analysis.

Bellgardt M, Bomberg H, Herzog-Niescery J, Dasch B, Vogelsang H, Weber TP, Steinfort C, Uhl W, Wagenpfeil S, Volk T, Meiser A.

Eur J Anaesthesiol. 2016 Jan;33(1):6-13. doi: 10.1097/EJA.0000000000000252.

PMID:
25793760
39.

Early recognition of possible pitfalls in histological diagnosis of celiac disease.

Eigner W, Wrba F, Chott A, Bashir K, Primas C, Eser A, Vogelsang H.

Scand J Gastroenterol. 2015;50(9):1088-93. doi: 10.3109/00365521.2015.1017835. Epub 2015 Feb 19.

PMID:
25697948
40.

Withdrawal of long-term maintenance treatment with azathioprine tends to increase relapse risk in patients with Crohn's disease.

Wenzl HH, Primas C, Novacek G, Teml A, Öfferlbauer-Ernst A, Högenauer C, Vogelsang H, Petritsch W, Reinisch W.

Dig Dis Sci. 2015 May;60(5):1414-23. doi: 10.1007/s10620-014-3419-5. Epub 2014 Nov 8.

PMID:
25381202
41.

Multicenter double-blinded randomized controlled trial of standard abdominal wound edge protection with surgical dressings versus coverage with a sterile circular polyethylene drape for prevention of surgical site infections: a CHIR-Net trial (BaFO; NCT01181206).

Mihaljevic AL, Schirren R, Özer M, Ottl S, Grün S, Michalski CW, Erkan M, Jäger C, Reiser-Erkan C, Kehl V, Schuster T, Roder J, Clauer U, Orlitsch C, Hoffmann TF, Lange R, Harzenetter T, Steiner P, Michalski M, Henkel K, Stadler J, Pistorius GA, Jahn A, Obermaier R, Unger R, Strunk R, Willeke F, Vogelsang H, Halve B, Dietl KH, Hilgenstock H, Meyer A, Krämling HJ, Wagner M, Schoenberg MH, Zeller F, Schmidt J, Friess H, Kleeff J.

Ann Surg. 2014 Nov;260(5):730-7; discussion 737-9. doi: 10.1097/SLA.0000000000000954.

PMID:
25379844
42.

[Nutrition and IBD-Consensus of the Austrian Working Group of IBD (Inflammatory Bowel Diseases) of the ÖGGH].

Fuchssteiner H, Nigl K, Mayer A, Kristensen B, Platzer R, Brunner B, Weiß I, Haas T, Benedikt M, Gröchenig HP, Eisenberger A, Hillebrand P, Reinisch W, Vogelsang H.

Z Gastroenterol. 2014 Apr;52(4):376-86. doi: 10.1055/s-0034-1366252. Epub 2014 Apr 9. German.

PMID:
24718944
43.

Follow-up of pediatric celiac disease: value of antibodies in predicting mucosal healing, a prospective cohort study.

Vécsei E, Steinwendner S, Kogler H, Innerhofer A, Hammer K, Haas OA, Amann G, Chott A, Vogelsang H, Schoenlechner R, Huf W, Vécsei A.

BMC Gastroenterol. 2014 Feb 13;14:28. doi: 10.1186/1471-230X-14-28.

44.

[Adalimumab for the treatment of ulcerative colitis--a consensus report by the working group inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology].

Novacek G, Dejaco C, Knoflach P, Moschen A, Petritsch W, Vogelsang H, Reinisch W.

Z Gastroenterol. 2014 Feb;52(2):204-11. doi: 10.1055/s-0033-1355818. Epub 2014 Jan 31. German.

PMID:
24488763
45.

Increased responsiveness to thrombin through protease-activated receptors (PAR)-1 and -4 in active Crohn's disease.

Schmid W, Vogelsang H, Papay P, Primas C, Eser A, Gratzer C, Handler M, Novacek G, Panzer S.

J Crohns Colitis. 2014 Jun;8(6):495-503. doi: 10.1016/j.crohns.2013.11.001. Epub 2013 Dec 2.

PMID:
24291018
46.

Effects of liberal vs. conventional volume regimen on pulmonary function in posterior scoliosis surgery.

Niescery J, Huhmann N, Dasch B, Bullmann V, Weber TP, Bellgardt M, Vogelsang H.

Middle East J Anaesthesiol. 2013 Jun;22(2):165-71.

PMID:
24180165
47.

[Adalimumab for the treatment of adult Crohn's disease--update of a consensus report by the Working Group Inflammatory Bowel Disease of the Austrian Society of Gastroenterology and Hepatology].

Novacek G, Haas T, Knoflach P, Petritsch W, Tilg H, Vogelsang H, Reinisch W.

Z Gastroenterol. 2013 Sep;51(9):1101-9. doi: 10.1055/s-0033-1350165. Epub 2013 Aug 30. German. Erratum in: Z Gastroenterol. 2013 Sep;51(9):E2.

PMID:
23996653
48.

A combined biochemical, biophysical and immunological approach towards the identification of celiac disease-specific wheat antigens.

Srinivasan B, Focke-Tejkl M, Swoboda I, Constantin C, Mittermann I, Pahr S, Vogelsang H, Huber WD, Valenta R.

Amino Acids. 2013 Oct;45(4):889-900. doi: 10.1007/s00726-013-1537-6. Epub 2013 Jul 9.

PMID:
23836418
49.

Renal insufficiency in IBD--prevalence and possible pathogenetic aspects.

Primas C, Novacek G, Schweiger K, Mayer A, Eser A, Papay P, Gratzer C, Angelberger S, Dejaco C, Reinisch W, Vogelsang H.

J Crohns Colitis. 2013 Dec;7(12):e630-4. doi: 10.1016/j.crohns.2013.05.001. Epub 2013 May 21.

PMID:
23706934
50.

[Colorectal cancer: screening and surveillance in inflammatory bowel diseases - consensus of the working group for inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology].

Angelberger S, Campregher C, Fuchssteiner H, Gasche C, Gröchenig HP, Haas T, Kazemi-Shirazi L, Mayer A, Miehsler W, Platzer R, Reinisch W, Steiner P, Tilg H, Tillinger W, Vogelsang H, Novacek G.

Z Gastroenterol. 2013 May;51(5):450-7. doi: 10.1055/s-0033-1335252. Epub 2013 May 16. German.

PMID:
23681899

Supplemental Content

Loading ...
Support Center